Insights from 2023 ASCO® Annual Meeting
Playback speed
10 seconds
Concurrent Chemo-Hormonal Therapy of Enzalutamide and Cabazitaxel in Patients With mCRPC: Final Analysis of ORR, rPFS, and OS
341 views
September 12, 2023
Comments 0
Login to view comments.
Click here to Login
GU